Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Medicines (Basel, Switzerland)|October 27, 2018
Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?Purushottam Lamichhane, Neha P Amin, Manuj Agarwal, et al.Cancer Metastasis Reviews|December 30, 2014
Targeted immune therapy of ovarian cancerKeith L Knutson, Lavakumar Karyampudi, Purushottam Lamichhane, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2015
Tumor-infiltrating dendritic cells in cancer pathogenesisJo Marie Tran Janco, Purushottam Lamichhane, Lavakumar Karyampudi, et al.Translational Oncology|March 2, 2020
Resistance to Checkpoint Inhibition in Cancer ImmunotherapyLuisa Barrueto, Francheska Caminero, Lindsay Cash, et al.International Journal of Molecular Sciences|July 19, 2020
Immunotherapies and Combination Strategies for Immuno-OncologyCody Barbari, Tyler Fontaine, Priyanka Parajuli, et al.Molecules (Basel, Switzerland)|July 8, 2020
The War against Tuberculosis: A Review of Natural Compounds and Their DerivativesMorgan Maiolini, Stacey Gause, Jerika Taylor, et al.Cancer Research|April 15, 2014
Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibodyLavakumar Karyampudi, Purushottam Lamichhane, Adam D Scheid, et al.Cancers|May 9, 2020
Colorectal Cancer and Probiotics: Are Bugs Really Drugs?Purushottam Lamichhane, Morgan Maiolini, Omar Alnafoosi, et al.Medicines (Basel, Switzerland)|August 3, 2019
Novel Delivery Systems for Checkpoint InhibitorsPurushottam Lamichhane, Rahul Deshmukh, Julie A Brown, et al.Cancer Research|August 30, 2018
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic CancerNagaraj S Nagathihalli, Jason A Castellanos, Purushottam Lamichhane, et al.Pageof 2